Skip to main content
[Preprint]. 2024 Feb 12:2024.02.06.24302387. [Version 2] doi: 10.1101/2024.02.06.24302387

Table 1.

Demographic characteristics of patients tested for respiratory syncytial virus.

Pre-pandemic phase Jul 2013 – Mar 2020 N = 210,424 tests Post-emergence phase Apr 2021 – Jun 2023 N = 723,460 tests P-value
Age (months) 8.57 (3.12–20.01) 35.05 (11.99–88.21) < 0.001
Age Category (%):
 • 0–90 days
 • 3–6 months
 • 6–12 months
 • 1–2 years
 • 2–4 years
 • 5–17 years
 • 23.91%
 • 15.63%
 • 20.29%
 • 19.38%
 • 9.99%
 • 10.81%
 • 8.50%
 • 5.73%
 • 10.77%
 • 15.63%
 • 17.57%
 • 41.80%
< 0.001
Sex (% male) 55.84% 54.19% < 0.001
Race (%)
 • White
 • Black
 • Asian
 • Pacific Islander
 • American Indian
 • Other
 • Multiple
 • Unknown
 • 43.94%
 • 24.00%
 • 2.31%
 • 0.35%
 • 0.23%
 • 9.91%
 • 1.15%
 • 18.11%
 • 48.89%
 • 23.07%
 • 4.33%
 • 0.45%
 • 0.35%
 • 13.73%
 • 3.22%
 • 5.96%
< 0.001
Ethnicity (%)
 • Hispanic or Latino
 • Not Hispanic or Latino
 • Unknown
 • 31.59%
 • 62.80%
 • 5.61%
 • 30.67%
 • 63.81%
 • 5.51%
< 0.001
Complex Chronic Condition by Age Group (%)
 • 0–90 days
 • 3–6 months
 • 6–12 months
 • 1–2 years
 • 2–4 years
 • 5+ years
18.45%
 • 13.77%
 • 10.55%
 • 11.39%
 • 14.64%
 • 27.68%
 • 51.75%
15.84%
 • 14.58%
 • 17.38%
 • 11.62%
 • 10.02%
 • 8.50%
 • 2.23%
< 0.001
 • < 0.001
 • < 0.001
 • < 0.001
 • < 0.001
 • < 0.001
 • < 0.001
Premature or Neonatal Complex Chronic Condition (%) 2.71% 1.64% < 0.001
Patient Type
 • ED (Discharge)
 • ED & IP (ED Admit)
 • IP (Direct Admit)
 • 56.60%
 • 34.73%
 • 8.67%
 • 66.34%
 • 27.00%
 • 6.66%
< 0.001
Diagnostic Test (%)
 • Culture
 • Antigen
 • PCR
 • DNA Probe
 • SARS-CoV-2 Multi-Pathogen
 • Other/Unspecified Test
 • Multiple Tests
 • 3.05%
 • 83.39%
 • 5.26%
 • 4.77%
 • 0%
 • 0.01%
 • 3.52%
 • 0.26%
 • 7.52%
 • 10.78%
 • 0.14%
 • 80.78%
 • <0.01%
 • 0.52%
< 0.001
Test Positivity by Diagnostic (%)
 • Culture
 • Antigen
 • PCR
 • DNA Probe
 • SARS-CoV-2 Multi-Pathogen
21.50%
 • 9.64%
 • 23.03%
 • 18.16%
 • 7.68%
 • NA
7.48%
 • 9.24%
 • 12.02%
 • 10.97%
 • 6.20%
 • 6.59%
< 0.001
 • 0.615
 • < 0.001
 • < 0.001
 • 0.090
 • NA
Test Positivity by Age Group (%)
 • 0–90 days
 • 3–6 months
 • 6–12 months
 • 1–2 years
 • 2–4 years
 • 5+ years
 • 26.30%
 • 27.47%
 • 22.62%
 • 20.35%
 • 18.03%
 • 5.46%
 • 14.58%
 • 17.38%
 • 11.62%
 • 10.02%
 • 8.50%
 • 2.23%
 • < 0.001
 • < 0.001
 • < 0.001
 • < 0.001
 • < 0.001
 • < 0.001

Medians (with interquartile ranges) are used to summarize distributions of continuous variables. ED, emergency department. IP, inpatient. NA, not applicable. PCR, polymerase chain reaction.